View in EDS

Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.

Saved in:

Bibliographic Details
Title:	Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.
Authors:	Kang YP; Department of Cancer Physiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, United States., Torrente L; Department of Cancer Physiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, United States., Falzone A; Department of Cancer Physiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, United States., Elkins CM; Department of Cancer Physiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, United States., Liu M; Proteomics and Metabolomics Core Facility, H Lee Moffitt Cancer Center and Research Institute, Tampa, United States., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, United States.; Department of Medicine, Harvard Medical School, Boston, United States., Dibble CC; Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, United States.; Department of Pathology, Harvard Medical School, Boston, United States., DeNicola GM; Department of Cancer Physiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, United States.
Source:	ELife [Elife] 2019 May 20; Vol. 8. Date of Electronic Publication: 2019 May 20.
Publication Type:	Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2050-084X
DOI:	10.7554/eLife.45572